Ethical Considerations for Artificial Intelligence in Medical Imaging: Deployment and Governance

Jonathan Herington, Melissa D. McCradden, Kathleen Creel, Ronald Boellaard, Elizabeth C. Jones, Abhinav K. Jha, Arman Rahmim, Peter J.H. Scott, John J. Sunderland, Richard L. Wahl, Sven Zuehlsdorff, Babak Saboury

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


The deployment of artificial intelligence (AI) has the potential to make nuclear medicine and medical imaging faster, cheaper, and both more effective and more accessible. This is possible, however, only if clinicians and patients feel that these AI medical devices (AIMDs) are trustworthy. Highlighting the need to ensure health justice by fairly distributing benefits and burdens while respecting individual patients’ rights, the AI Task Force of the Society of Nuclear Medicine and Molecular Imaging has identified 4 major ethical risks that arise during the deployment of AIMD: autonomy of patients and clinicians, transparency of clinical performance and limitations, fairness toward marginalized populations, and accountability of physicians and developers. We provide preliminary recommendations for governing these ethical risks to realize the promise of AIMD for patients and populations.

Original languageEnglish
Pages (from-to)1509-1515
Number of pages7
JournalJournal of Nuclear Medicine
Issue number10
StatePublished - Oct 1 2023


  • AI ethics
  • explainability
  • fairness
  • justice
  • software as medical device


Dive into the research topics of 'Ethical Considerations for Artificial Intelligence in Medical Imaging: Deployment and Governance'. Together they form a unique fingerprint.

Cite this